ClinicalTrials.gov
ClinicalTrials.gov Menu

Physical Activity and Glycemic Control

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00881972
Recruitment Status : Completed
First Posted : April 16, 2009
Last Update Posted : September 24, 2015
Sponsor:
Information provided by (Responsible Party):
University of Kansas Medical Center

Brief Summary:
This study will test the effects of daily physical activity on variations in blood glucose control.

Condition or disease Intervention/treatment Phase
Insulin Resistance Behavioral: Exercise Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Physical Activity and Glycemic Control
Study Start Date : February 2009
Actual Primary Completion Date : May 2010
Actual Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: exercise Behavioral: Exercise
walking/running/cycling



Primary Outcome Measures :
  1. Blood glucose fluctuations [ Time Frame: days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Young, healthy

Exclusion Criteria:

  • Chronic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00881972


Locations
United States, Missouri
University of Missouri-Columbia
Columbia, Missouri, United States, 65201
Sponsors and Collaborators
University of Kansas Medical Center
Investigators
Principal Investigator: John P Thyfault, PhD Univerisity of Missouri-Columbia

Responsible Party: University of Kansas Medical Center
ClinicalTrials.gov Identifier: NCT00881972     History of Changes
Other Study ID Numbers: 1116098
First Posted: April 16, 2009    Key Record Dates
Last Update Posted: September 24, 2015
Last Verified: September 2015

Additional relevant MeSH terms:
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases